Vext Science Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Vext Science has a total shareholder equity of $87.0M and total debt of $35.3M, which brings its debt-to-equity ratio to 40.6%. Its total assets and total liabilities are $144.9M and $57.9M respectively.

Anahtar bilgiler

40.6%

Borç/özkaynak oranı

US$35.28m

Borç

Faiz karşılama oranın/a
NakitUS$3.39m
EşitlikUS$87.00m
Toplam yükümlülüklerUS$57.88m
Toplam varlıklarUS$144.88m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: VV5's short term assets ($27.1M) exceed its short term liabilities ($17.1M).

Uzun Vadeli Yükümlülükler: VV5's short term assets ($27.1M) do not cover its long term liabilities ($40.8M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: VV5's net debt to equity ratio (36.7%) is considered satisfactory.

Borcun Azaltılması: VV5's debt to equity ratio has increased from 4.2% to 40.6% over the past 5 years.

Borç Kapsamı: VV5's debt is not well covered by operating cash flow (1.4%).

Faiz Kapsamı: Insufficient data to determine if VV5's interest payments on its debt are well covered by EBIT.


Bilanço


Sağlıklı şirketleri keşfedin